A total of 1085 strains of Acinetobacter sp. obtained from 280 medical institutions in the Chugoku and Shikoku areas of Japan were investigated between 2011 and 2013. Among these strains, 20 (1.84 %) showing meropenem or imipenem resistance with a MIC of .4 mg ml 21 were detected. Of these 20 strains, the bla OXA-23 gene was detected in 17 strains isolated from the same institution. The PFGE patterns of the 17 strains were separated into two clusters, and multi-locus sequence typing showed the sequence types (STs) to be ST2 and ST246. This investigation demonstrated that A. baumannii ST2 of international clone II, which has rarely been isolated in Japan, has not yet spread nationwide.
INTRODUCTION
Recently, cases of multidrug-resistant isolates of Acinetobacter baumannii have been reported (Abbo et al., 2005) . Acinetobacter spp., which are a frequent cause of nosocomial infections, have acquired various resistance mechanisms (Bergogne-Bérézin & Towner, 1996) . The main resistance mechanism is associated with the production of metallo-b-lactamases belonging to Ambler class B and oxacillinases belonging to Ambler class D (Nordmann & Poirel, 2002; Brown & Amyes, 2006) . It has been found that the bla OXA-51 -like gene is intrinsic to A. baumannii, and acquired OXA genes are divided into three subgroups, bla OXA-23 -, bla OXA-40 -and bla OXA-58 -like genes (Evans & Amyes, 2014) . The SENTRY Antimicrobial Surveillance Program, which investigated the situation of OXA-type carbapenemases in the Asia-Pacific region (excluding Japan) between 2006 and 2007, revealed that the bla OXA-23 carbapenemase gene was widely distributed in the Asia-Pacific region. The results of the investigation confirmed that, among 230 strains of carbapenem-non-susceptible Acinetobacter spp. isolated in six countries -China, Hong Kong, India, Korea, Singapore and Thailand -class D carbapenemases were detected in 160.
Of these 160 strains, 156 were A. baumannii, of which 134 were confirmed to have bla OXA-23 carbapenemase genes (Mendes et al., 2009) . In contrast, outbreaks of multidrugresistant A. baumannii in institutions (Yuji et al., 2011; Yoshida et al., 2014) and detection of metallo-b-lactamaseproducing A. baumannii (Yokozawa et al., 2012) have been reported in Japan, but strains carrying the bla OXA-23 carbapenemase gene have been distributed only sporadically (Endo et al., 2012; Yasuhara et al., 2013) .
In the present study, 1085 strains of Acinetobacter sp. isolated from clinical specimens were collected from 280 medical institutions in Japan, and molecular biological analyses were performed as a large-scale investigation of carbapenem-resistant A. baumannii. (CLSI, 2009a) were used for determining susceptibility. In the carbapenem-resistant strains, the 16S-23S rRNA gene intergenic spacer was sequenced to identify the genomic species (Chang et al., 2005) , and MICs of various antimicrobial agents were determined by DP35 panel (Eiken Co.) using the CLSI standard broth microdilution method (CLSI, 2009b) .
Phenotypical analysis of b-lactamase. A sodium mercaptoacetic acid inhibition test using disks of ceftazidime and meropenem (Arakawa et al., 2000) and a three-dimensional test using disks of meropenem and imipenem (Coudron et al., 2000) were performed to confirm carbapenemase production. A double-disk synergy test was also performed (Yagi et al., 2005) to confirm the production of AmpC b-lactamase, in which 20 ml 3-aminophenylboronic acid at 30 mg ml 21 was added to a blank disk and set in the centre of Mueller-Hinton agar; the ceftazidime and meropenem disks were then placed close to the disk containing 3-aminophenylboronic acid.
Genotypic analysis of b-lactamase genes and sequencing of the bla OXA-23 and bla OXA-51 genes. The phyletic group of bla OXA-51 , bla OXA-58 , bla OXA-23 and bla OXA-40 was detected by multiplex PCR according to the method of Queenan and Bush (2007) . Determination of the presence of the ISAba1 insertion sequence upstream of the bla OXA-23 and bla OXA-51 genes was performed by PCR in combination with an amplifier primer as described in the method of Turton et al. (2006) . Direct reaction sequencing of the PCR product was done using a BigDye Terminator v.3.1 Cycle Sequencing kit (Thermo Fisher Scientific) and it was analysed with an Applied Biosystems 3730xl DNA Analyser (Thermo Fisher Scientific). PFGE analysis. PFGE was performed based on the method of Seifert et al. (2005) . The restriction enzyme was Apa I, and the device used was a CHEF-DR II system (Bio-Rad Laboratories). The reaction conditions were as follows: running parameters of 6.0 V cm 21 , 5.3 s initial switching time, 34.9 s final switching time and 19.5 h total running time at 14 uC. Dendrograms were calculated using Fingerprinting Plus v.1.12 (Bio-Rad Laboratories) with Dice coefficients and the unweighted pair group method using arithmetic averages.
Multilocus sequence typing (MLST) analysis. The sequences of seven housekeeping genes (cpn60, fusA, gltA, pyrG, recA, rplB and rpoB) were determined by MLST, which was performed according to the method developed at the Pasteur Institute (http://www.pasteur.fr/ recherche/genopole/PF8/mlst/).
Isoelectric focusing (IEF). IEF was conducted according to the method of Komatsu et al. (2001) . A polyacrylamide gel containing ampholyte (Bio-Lyte 3/10; Bio-Rad Laboratories) was prepared. Crude enzyme was extracted by freezing and thawing the culture medium, and the adjusted total protein concentration of 1 mg ml 21 was analysed by IEF using a model 111 Mini IEF Cell (Bio-Rad Laboratories). b-Lactamase activity was detected by overlaying the gel with a filter paper containing nitrocefin at 0.5 mg ml 21 .
RESULTS

Isolation frequency of carbapenem-resistant A. baumannii and MICs
A total of 1085 strains of Acinetobacter sp. were isolated from various clinical specimens obtained from 280 medical institutions between 2011 and 2013. Among these strains, 20 (1.84%) that showed meropenem or imipenem resistance, as indicated by a MIC of w4 mg ml 21 , was detected (Table 1) . Of these 20 strains, 18 were isolated in the same institution, and the MICs of the 20 isolates showed that seven were susceptible to and 13 were resistant to ceftazidime. All 20 of these carbapenem-resistant strains were identified as A. baumannii.
Phenotypic analysis of b-lactamase
The sodium mercaptoacetic acid inhibition test was negative in all 20 strains, and the three-dimensional test was positive in 19 strains. Only 13 strains showing resistance to ceftazidime were positive in the 3-aminophenylboronic acid inhibition test, and strains showing the 3-aminophenylboronic acid inhibitory reaction did not grow on the meropenem disk (Table 1) .
Genotyping of OXA-type b-lactamase and sequencing of the bla OXA-23 and bla OXA-51 genes When classified by OXA-type carbapenemase-producing genetic type, all 20 strains were confirmed to carry the bla OXA-51 -like gene, and 17 strains carrying the bla OXA-23 gene were also detected (Table 1 ). The sequence of the bla OXA-23 -like gene completely matched that of GenBank accession no. AJ132105.1. In addition, in all strains, ISAba1 was detected upstream of the bla OXA-23 gene. The remaining three strains that did not carry the bla OXA-23 gene were confirmed to have ISAba1 upstream of the bla OXA-51 -like gene. However, the 17 strains that carried the bla OXA-23 gene were confirmed not to have ISAba1 upstream of the bla OXA-51 -like gene.
PFGE analysis
PFGE patterns and dendrograms of the 20 strains are shown in Fig. 1 . Based on the dendrogram analysis (Fig. 1) , the 20 strains were divided into two clusters. The 17 bla OXA-23 gene-positive strains were divided into two clusters (PFGE cluster A and cluster B). Cluster A was divided into a group of 10 strains carrying the bla OXA-23 gene and a group of three strains carrying the bla OXA-51-like gene and not the bla OXA-23 gene. Members of cluster B carried the bla OXA-23 gene and were susceptible to ceftazidime.
MLST analysis
All strains in the group classified as cluster A by PFGE were sequence type 2 (ST2) (allelic profile 2/2/2/2/2/2/2), and all strains in the group of cluster B were ST246 (allelic profile 1/49/3/4/5/2/36). A. baumannii strains isolated in that country, 44 (58.6%) exhibited resistance to imipenem, meropenem and ceftazidime. Of the 44 strains, the bla OXA-23 -like gene was detected in 26 (59.1%), and their PFGEs had identical or similar patterns. Compared with the reports described above, in this study, carbapenem-resistant strains were detected in only three of the 280 institutions. In addition, this study revealed that most of the carbapenem-resistant genes were the bla OXA-23 gene, whose prevalence was extremely low, at 1.57%. In the present survey, the frequency of appearance of carbapenem-resistant Acinetobacter sp. was estimated using clinical isolates obtained in a hospital without a bacterial laboratory, and the frequency could be underestimated in comparison with that in reports from large academic institutions.
Strains not carrying the bla OXA-23 gene had ISAba1 upstream of the bla OXA-51 -like gene, whereas the strains that did carry the bla OXA-23 gene did not have ISAba1 upstream of the bla OXA-51 -like gene. In addition, regarding carbapenems, the imipenem MICs of the three strains not carrying the bla OXA-23 gene were one to two dilutions lower than those of the strains carrying the bla OXA-23 gene. ST246 was reported as a new ST of fluoroquinolone-resistant A. baumannii by Higuchi et al. (2014) . The ST246 isolated in this study was susceptible to levofloxacin (MIC of 2 or j1 mg ml
21
). ST246 is reportedly still rare, but attention should be paid to its future trend. The prevalence of different Y. Kubo and others bacterial clones carrying identical genes in a single institution indicates the possibility that, in A. baumannii carrying the bla OXA-23 gene, for which MLST has indicated outbreaks of ST2 in many countries, the plasmid was transmitted to ST246, which was concurrently detected.
On the basis of the IEF analysis of b-lactamase activity, Jeon et al. (2005) reported that all 36 A. baumannii strains carrying the bla OXA-23 gene had an acknowledged band at pI 6.65, and Zhou et al. (2007) confirmed a single band at pI 6.64. Naas et al. (2005) also confirmed the expression of the bla OXA-23 gene (pI 6.9), the chromosomal class C b-lactamase (pI w9.0) and bla TEM-1 (pI 5.4). The results of our IEF analysis revealed that the strains carrying the bla OXA-23 gene had bands exhibiting strong enzyme activity at pI w9.0, suggesting ADC b-lactamase, but no band equivalent to that of the bla OXA-23 gene was detected.
Ceftazidime resistance was presumed to be due to the enzyme activity of ADC b-lactamase, strains of which were positive in the 3-aminophenylboronic acid inhibition test but negative in the same test using the meropenem disk.
Meropenem and imipenem resistance mechanisms were suspected to originate from carbapenemase production because the three-dimensional test using the carbapenem disk was positive. However, the results were inconsistent with those of the IEF analysis, and thus it remains unclear whether the carbapenem-resistance mechanism originated from the bla OXA-23 gene. Yigit et al. (2002) reported that the carbapenem-resistance mechanism of Enterobacter aerogenes originated from chromosomal AmpC production and decreased expression of the bacterial strain due to the lack of outer-membrane protein. Lee et al. (2010) reported that excessive expression of the bla OXA-23 gene and AdeABC efflux pump, located on the chromosomes, were related to the acquisition of carbapenem resistance in A. baumannii. We considered the possibility that similar factors are involved in bla OXA-23 production and the carbapenem resistance of the A. baumannii carrying the bla OXA-23 gene in this analysis. Consequently, our study demonstrated that, in comparison with investigations of carbapenem-resistant strains in other Asian countries, the isolation frequency of these strains in Japan is still very low. This report indicates that A. baumannii carrying the bla OXA-23 gene undoubtedly represents a new threat to healthcare-associated infection control, and clinical microbiological laboratories should have schemes in place to identify A. baumannii carrying the bla OXA-23 gene and pay attention to its future trend.
